Skip to main content
. 2018 Apr 25;15(6):5231–5242. doi: 10.3892/etm.2018.6097

Figure 3.

Figure 3.

Cellular ROS levels following treatment of ARVMs with rhSLPI. ARVMs were incubated with carboxy-H2DCFDA and treated with 0, 200, 400, 600, 800 and 1,000 ng/ml rhSLPI. Following incubation, H2O2 was applied to each group and ROS production was determined using the EnSpire Multimode Plate Reader. Data are presented as the mean ± standard error of the mean (n=3). *P<0.05 vs. control group; #P<0.05 vs. H2O2 treated group. ROS, reactive oxygen species; ARVM, adult rat ventricular myocytes; rhSLPI, recombinant human secretory leukocyte protease inhibitor; A.U., arbitrary unit.